Protective effects of fenofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats

Pharmaceutical Biology

Volumn 54, Issue 9, 2016, Pages 1705-1715

  Wahba, Mariam G F ^a   Messiha, Basim A S ^b   Abo Saif, Ali A ^b  

^a Nahda University Beni Suef   (Egypt)

^b Beni Suef University   (Egypt)

Author keywords

Anti inflammatory; antioxidant; complete Freund s adjuvant; dexamethasone; immuno modulatory; methotrexate

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CYTOKINE; DEXAMETHASONE; FENOFIBRATE; GLUTATHIONE; IMMUNOGLOBULIN G; MALONALDEHYDE; METHOTREXATE; MYELOPEROXIDASE; RESVERATROL; RHEUMATOID FACTOR; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ANTIRHEUMATIC AGENT; AUTACOID; BIOLOGICAL MARKER; FREUND ADJUVANT; IMMUNOSUPPRESSIVE AGENT; STILBENE DERIVATIVE;

ADULT; ALBINO RAT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FREUND ADJUVANT-INDUCED ARTHRITIS; HISTOPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; RHEUMATOID ARTHRITIS; SPLEEN; ANIMAL; ARTHRITIS, EXPERIMENTAL; BLOOD; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; JOINT; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, EXPERIMENTAL; BIOMARKERS; CYTOKINES; DEXAMETHASONE; FEMALE; FENOFIBRATE; FREUND'S ADJUVANT; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; JOINTS; METHOTREXATE; OXIDATIVE STRESS; RATS, WISTAR; SPLEEN; STILBENES;

EID: 84951289973     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2015.1125931     Document Type: Article

References (78)

1. A.Al Maruf, P.O’Brien 2014. Flutamide-induced cytotoxicity and oxidative stress in an in vitro rat hepatocyte system. Oxid Med Cell Longev. 2014:Article ID 398285.
2. M.L.Andersson, B.Svensson, I.F.Petersson, I.Hafström, K.Albertsson, K.Forslind, D.Heinegård, T.Saxne. 2013. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis. BMC Musculoskelet Disord. 14:229–236.
3. S.J.Ann, J.H.Chung, B.H.Park, S.H.Kim, J.Jang, S.Park, S.M.Kang, S.H.Lee. 2015. PPARα agonists inhibit inflammatory activation of macrophages through upregulation of β-defensin 1. Atherosclerosis 240:389–397.
4. G.D.Banchroft, A.Steven 1983. Theory and practice of histological technique. 4th ed. London, UK:Churchill Livingstone Publications.
5. B.Bellaver, D.G.Souza, D.O.Souza, A.Quincozes-Santos. 2014. Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats. Toxicol in Vitro. 28:479–484.
6. R.Biesen, G.R.Burmester, F.Hiepe 2014. [Rheumatoid factor or antinuclear antibodies as incidental finding]. Internist (Berl). 55:1157–1164.
7. P.Brouckaert, C.Libert, B.Everaerdt, N.Takahashi, A.Cauwels, W.Fiers. 1993. Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology 187:317–329.
8. P.D.Brown 1998. Synthetic inhibitors of matrix metalloproteinases. In:W.C.Parks, R.P.Mecham, editors. Matrix metalloproteases. San Diego (CA):Academic Press. p. 243–261.
9. E.Castillero, A.I.Martín, M.P.Nieto-Bona, C.Fernández-Galaz, M.López-Menduiña, M.A.Villanúa, A.López-Calderón. 2012. Fenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting. Endocr Connect. 1:1–12.
10. X.Chen, J.Lu, M.An, Z.Ma, H.Zong, J.Yang. 2014. Anti-inflammatory effect of resveratrol on adjuvant arthritis rats with abnormal immunological function via the reduction of cyclooxygenase-2 and prostaglandin E2. Mol Med Rep. 9:2592–2598.
11. X.Y.Chen, Z.C.Wang, J.Li, X.L.Liu, Y.H.Sun. 2013. Regulation of synoviocyte activity by resveratrol in rats with adjuvant arthritis. Exp Ther Med. 6:172–176.
12. A.Cianciulli, T.Dragone, R.Calvello, C.Porro, T.Trotta, D.D.Lofrumento, M.A.Panaro. 2015. IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells. Int Immunopharmacol. 24:369–376.
13. S.R.Edupuganti, V.Eder, D.Ternant, M.Courtehoux, F.Tranquart, P.Goupille, G.Paintaud, D.Mulleman. 2015. F-18 fluorodeoxyglucose positron emission tomography can detect early response to adalimumab, a tumor necrosis factor-α antagonist, in rheumatoid arthritis:a prospective pilot study. Joint Bone Spine. 82:381–383
14. G.L.Ellman 1959. Tissue sulfhydryl groups. Arch Biochem Biophys. 82:70–77.
15. H.Esterbauer, R.J.Schaur, H.Zollner 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med. 11:81–128.
16. M.G.Fahmy Wahba, B.A.Shehata Messiha, A.A.Abo-Saif 2015. Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats. Eur J Pharmacol. 765:307–315
17. M.Glehr, M.Breisach, S.Walzer, B.Lohberger, F.Fürst, J.Friesenbichler, B.Rinner, A.Avian, R.Windhager, A.Leithner. 2013. The influence of resveratrol on the synovial expression of matrix metalloproteinases and receptor activator of NF-kappaB ligand in rheumatoid arthritis fibroblast-like synoviocytes. Z Naturforsch C. 68:336–342.
18. A.Gramoun, L.A.Crowe, L.Maurizi, W.Wirth, F.Tobalem, K.Grosdemange, G.Coullerez, F.Eckstein, M.I.Koenders, W.B.Van den Berg,. 2014. Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages. Arthritis Res Ther. 16:R131–R146.
19. B.Gretzer, N.Maricic, M.Respondek, R.Schuligoi, B.M.Peskar. 2001. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol. 132:1565–1573.
20. N.Haleagrahara, D.Tudawe, S.Chakravarthi, A.Kutty Radhakrishnan. 2013. Amelioration of collagen-induced arthritis in female dark agouti rats by glucosamine treatment. ISRN Pharmacol. 2013:Article ID 562905.
21. H.Haro, H.C.Crawford, B.Fingleton, J.R.MacDougall, K.Shinomiya, D.M.Spengler, L.M.Matrisian. 2000. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. J Clin Invest. 105:133–141.
22. B.Hügle, C.Hinze, E.Lainka, N.Fischer, J.P.Haas. 2014. Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course. Pediatr Rheumatol Online J. 12:28–32.
23. F.Ingegnoli, R.Castelli, R.Gualtierotti 2013. Rheumatoid factors:clinical applications. Dis Markers. 35:727–734.
24. S.S.Iyer, G.Cheng 2012. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 32:23–63.
25. S.Y.Kawashiri, A.Kawakami, Y.Ueki, T.Imazato, N.Iwamoto, K.Fujikawa, T.Aramaki, M.Tamai, H.Nakamura, T.Origuchi,. 2010. Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment:comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab. Joint Bone Spine. 77:418–420.
26. F.Khozeimeh, O.Savabi, M.Esnaashari 2014. Evaluation of interleukin-1α, interleukin-10, tumor necrosis factor-α and transforming growth factor-β in the serum of patients with Pemphigus vulgaris. J Contemp Dent Pract. 15:746–749.
27. S.Kim, J.H.Kim, J.H.Lee, H.S.Kim. 2010. Evaluation of three automated enzyme immunoassays for detection of anti-cyclic citrullinated peptide antibodies in qualitative and quantitative aspects. Rheumatology (Oxford). 49:450–457.
28. Y.H.Kim, J.S.Kang 2015. Effect of methotrexate on collagen-induced arthritis assessed by micro-computed tomography and histopathological examination in female rats. Biomol Ther (Seoul). 23:195–200.
29. K.Kizaki, Y.Yoshizumi, T.Takahashi, S.Era. 2015. Elevated oxidative stress monitored via the albumin-thiol redox state is correlated with matrix metalloproteinase-3 elevation in patients with rheumatoid arthritis. Clin Lab. 61:175–178.
30. M.Koufany, J.Y.Jouzeau, D.Moulin 2014. Fenofibrate vs pioglitazone:comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis. Biomed Mater Eng. 24:81–88.
31. K.G.Kripa, D.Chamundeeswari, J.Thanka, C.Uma Maheswara Reddy. 2010. Effect of hydroalcoholic extract of aerial parts of Leucas aspera (Willd.) link on inflammatory markers in complete Freund’s adjuvant induced arthritic rats. Int J Green Pharm. 4:281–287.
32. R.Krysiak, A.Gdula-Dymek, B.Okopien 2013. The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. Basic Clin Pharmacol Toxicol. 112:198–202.
33. C.E.Lampropoulos, P.Orfanos, V.K.Bournia, T.Karatsourakis, C.Mavragani, D.Pikazis, M.N.Manoussakis, A.G.Tzioufas, H.M.Moutsopoulos, P.G.Vlachoyiannopoulos. 2015. Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents:a real world study. Clin Exp Rheumatol. 33:216–224.
34. J.W.Lee, P.J.Bajwa, M.J.Carson, D.R.Jeske, Y.Cong, C.O.Elson, C.Lytle, D.S.Straus. 2007. Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice. Gastroenterology 133:108–123.
35. M.Lei, J.G.Wang, D.M.Xiao, M.Fan, D.P.Wang, J.Y.Xiong, Y.Chen, Y.Ding, S.L.Liu. 2012. Resveratrol inhibits interleukin 1β-mediated inducible nitric oxide synthase expression in articular chondrocytes by activating SIRT1 and thereby suppressing nuclear factor-κB activity. Eur J Pharmacol. 674:73–79.
36. X.Liu, A.J.Teichtahl, I.P.Wicks 2015. Interleukin-6 in rheumatoid arthritis – from the laboratory to the bedside. Curr Pharm Des. 21:2187–2197.
37. G.Lopalco, L.Cantarini, A.Vitale, F.Iannone, M.G.Anelli, L.Andreozzi, G.Lapadula, M.Galeazzi, D.Rigante. 2015. Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders:premises, perils, and perspectives. Mediators Inflamm. 2015:Article ID 194864.
38. E.Lubberts 2015. Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment. Curr Pharm Des. 21:142–146.
39. A.Mamehara, T.Sugimoto, D.Sugiyama, S.Morinobu, G.Tsuji, S.Kawano, A.Morinobu, S.Kumagai. 2010. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs. Kobe J Med Sci. 56:E98–E107.
40. A.Manktelow, A.A.Meyer 1986. Lack of correlation between decreased chemotaxis and susceptibility to infection in burned rats. J Trauma. 26:143–148.
41. L.Márk, J.Márki-Zay, I.Orosz, A.Kondacs, F.Erdei, A.Katona. 2003. [Pleiotropic effect of the micronized fenofibrate:the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease]. Orv Hetil. 144:765–768.
42. S.Maruyama, K.Kato, M.Kodama, S.Hirono, K.Fuse, O.Nakagawa, M.Nakazawa, T.Miida, T.Yamamoto, K.Watanabe,. 2002. Fenofibrate, a peroxisome proliferator-activated receptor alpha activator, suppresses experimental autoimmune myocarditis by stimulating the interleukin-10 pathway in rats. J Atheroscler Thromb. 9:87–92.
43. I.B.McInnes, G.Schett 2011. The pathogenesis of rheumatoid arthritis. N Engl J Med. 365:2205–2219.
44. M.M.Medeiros, B.M.Oliveira, J.V.Cerqueira, R.T.Quixadá, Í.M.Oliveira. 2015. Correlation of rheumatoid arthritis activity indexes (Disease Activity Score 28 measured with ESR and CRP, Simplified Disease Activity Index and Clinical Disease Activity Index) and agreement of disease activity states with various cut-off points in a Northeastern Brazilian population. Rev Bras Reumatol. 55:477–484.
45. A.Mobasheri, M.Shakibaei 2013. Osteogenic effects of resveratrol in vitro:potential for the prevention and treatment of osteoporosis. Ann N Y Acad Sci. 1290:59–66.
46. E.Moran, L.Ding, Z.Wang, R.Cheng, Q.Chen, R.Moore, Y.Takahashi, J.X.Ma. 2014. Protective and antioxidant effects of PPARα in the ischemic retina. Invest Ophthalmol Vis Sci. 55:4568–4576.
47. H.Nagase 1998. Matrix metalloproteinases. In:A.J.Barrett, N.D.Rawlings, J.F.Woessner, editors. Handbook of proteolytic enzymes. San Diego (CA):Academic Press. p. 1172–1178.
48. B.B.Newbound 1963. Chemotherapy of arthritis induced in rats by mycobacterial adjuvants. Br J Pharmacol Chemother. 21:127–136.
49. S.T.Ngo, F.J.Steyn, P.A.McCombe 2014. Gender differences in autoimmune disease. Front Neuroendocrinol. 35:347–369.
50. N.F.Nicoletti, V.Rodrigues-Junior, A.A.J.SantosAA Jr, C.E.Leite, A.C.Dias, E.L.J.BatistaEL Jr, L.A.Basso, M.M.Campos, D.S.Santos, A.A.Souto. 2014. Protective effects of resveratrol on hepatotoxicity induced by isoniazid and rifampicin via SIRT1 modulation. J Nat Prod. 77:2190–2195.
51. M.Osada, T.Sakai, K.Kuroyanagi, H.Kohno, H.Tsuneoka. 2014. Treatment of experimental autoimmune uveoretinitis with peroxisome proliferator-activated receptor α agonist fenofibrate. Mol Vis. 20:1518–1526.
52. R.Pangeni, S.Sharma, G.Mustafa, J.Ali, S.Baboota. 2014. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson’s disease by reducing oxidative stress. Nanotechnology 25:Article ID 485102.
53. S.S.Patel, P.V.Shah 2013. Evaluation of anti-inflammatory potential of the multidrug herbomineral formulation in male Wistar rats against rheumatoid arthritis. J Ayurveda Integr Med. 4:86–93.
54. M.Paulsson, D.Heinegård 1981. Purification and structural characterization of a cartilage matrix protein. Biochem J. 197:367–375.
55. S.G.Petersen, T.Saxne, D.Heinegard, M.Hansen, L.Holm, S.Koskinen, C.Stordal, H.Christensen, P.Aagaard, M.Kjaer. 2010. Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training. Osteoarthritis Cartilage. 18:34–40.
56. R.Rau 2014. Glucocorticoid treatment in rheumatoid arthritis. Expert Opin Pharmacother. 15:1575–1583.
57. A.Saxena, S.Khosraviani, S.Noel, D.Mohan, T.Donner, A.R.Hamad. 2014. Interleukin-10 paradox:a potent immunoregulatory cytokine that has been difficult to harness for immunotherapy. Cytokine 74:27–34.
58. D.R.Schultz, P.I.Arnold 1990. Properties of four acute phase proteins:C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum. 20:129–147.
59. S.Sharma, R.Gupta, S.C.Thakur 2014. Attenuation of collagen induced arthritis by Centella asiatica methanol fraction via modulation of cytokines and oxidative stress. Biomed Environ Sci. 27:926–938.
60. S.Singh, R.Kumar, H.Jain, Y.K.Gupta. 2015. Anti-inflammatory and antiarthritic activity of UNIM-301 (a polyherbal unani formulation) in Wistar rats. Pharmacognosy Res. 7:188–192.
61. U.Snekhalatha, M.Anburajan, B.Venkatraman, M.Menaka. 2013. Evaluation of complete Freund’s adjuvant-induced arthritis in a Wistar rat model. Comparison of thermography and histopathology. Z Rheumatol. 72:375–382.
62. L.K.Stamp, I.Khalilova, J.M.Tarr, R.Senthilmohan, R.Turner, R.C.Haigh, P.G.Winyard, A.J.Kettle. 2012. Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology (Oxford). 51:1796–1803.
63. J.F.Su, C.J.Guo, J.Y.Wei, J.J.Yang, Y.G.Jiang, Y.F.Li. 2003. Protection against hepatic ischemia-reperfusion injury in rats by oral pretreatment with quercetin. Biomed Environ Sci. 16:1–8.
64. M.Suwalsky, F.Villena, M.J.Gallardo 2015. In vitro protective effects of resveratrol against oxidative damage in human erythrocytes. Biochim Biophys Acta. 1848:76–82.
65. J.Tian, J.W.Chen, J.S.Gao, L.Li, X.Xie. 2013. Resveratrol inhibits TNF-α-induced IL-1β, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway. Rheumatol Int. 33:1829–1835.
66. G.Valesini, M.C.Gerardi, C.Iannuccelli, V.A.Pacucci, M.Pendolino, Y.Shoenfeld. 2015. Citrullination and autoimmunity. Autoimmun Rev. 14:490–497.
67. N.Vivar, R.F.Van Vollenhoven 2014. Advances in the treatment of rheumatoid arthritis. Hand Clin. 6:31–39.
68. C.A.von Mühlen, E.M.Tan 1995. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 24:323–358.
69. E.Waaler 2007. On the occurrence of a factor in human serum activating the specific agglutintion of sheep blood corpuscles. APMIS 115:422–438.
70. W.Wei, S.Clockaerts, Y.M.Bastiaansen-Jenniskens, L.M.Gierman, S.M.Botter, S.M.Bierma-Zeinstra, H.Weinans, J.A.Verhaar, M.Kloppenburg, A.M.Zuurmond,. 2014. Statins and fibrates do not affect development of spontaneous cartilage damage in STR/Ort mice. Osteoarthritis Cartilage. 22:293–301.
71. J.Wu, X.Liu, C.O.Chan, D.K.Mok, S.W.Chan, Z.Yu, S.Chen. 2014. Petroleum ether extractive of the hips of Rosa multiflora ameliorates collagen-induced arthritis in rats. J Ethnopharmacol. 157:45–54.
72. F.J.Yang, Y.H.He, J.H.Zhou 2015. Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury. J Huazhong Univ Sci Technol Med Sci. 35:58–63.
73. Y.Yu, S.Li, Y.Liu, G.Tian, Q.Yuan, F.Bai, W.Wang, Z.Zhang, G.Ren, Y.Zhang,. 2015. Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway. Int Immunopharmacol. 25:74–82.
74. J.Yuan, L.Lu, Z.Zhang, S.Zhang. 2012. Dietary intake of resveratrol enhances the adaptive immunity of aged rats. Rejuvenation Res. 15:507–515.
75. W.Zhang, J.Zhang, M.Zhang, L.Nie. 2014. Protective effect of Asarum extract in rats with adjuvant arthritis. Exp Ther Med. 8:1638–1642.
76. Z.Zhou, W.Sun, Y.Liang, Y.Gao, W.Kong, Y.Guan, J.Feng, X.Wang. 2012. Fenofibrate inhibited the differentiation of T helper 17 cells in vitro. PPAR Res. 2012:Article ID 145654.
77. X.Zhu, Q.Liu, M.Wang, M.Liang, X.Yang, X.Xu, H.Zou, J.Qiu. 2011. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PLoS One 6:e27081.
78. 4+ T cell activation by enhancing the expression and activity of Sirt1. PLoS One 8:e75139.